Endocyte is currently sponsoring clinical trials related to several oncology product candidates.  Study details are available from the clinicaltrials.gov website by clicking on the links below:

EC145 – folate-receptor targeted chemotherapy:

--Phase 2 trial for patients with ovarian cancer
--Phase 2 trial for patients with non-small cell lung cancer (NSCLC)

EC17 -  folate receptor targeted hapten:

--Phase 2 renal (kidney) cell carcinoma trial

EC0225 – folate-receptor targeted  chemotherapy:

--Phase 1 solid tumor trial

Medical Professionals requiring additional information may contact clinical@endocyte.com.

Relevant publications:

EC145: ASCO 2007 Annual Meeting

EC17: ASCO 2007 Annual Meeting